Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP: CVSI )

0.6250 USD -0.0050 (-0.79%)
Official Closing Price Updated: 3:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Cv Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
CV Sciences, Inc. Announces Launch of ProCBD™ Product Line
Clinical Strength ProCBD™ is Supported by Clinical Research and Available Exclusively Through Health Practitioners 
From GlobeNewswire News Releases
CV Sciences, Inc. Receives Nutritional Outlook’s 2020 Best of the Industry Award
From GlobeNewswire News Releases
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction
From GlobeNewswire News Releases
CV Sciences, Inc. Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
CV Sciences, Inc. Announces Launch of PlusCBD™ Pet Product Line
Full line of soothing hemp extracts formulated exclusively for dogs and cats 
From GlobeNewswire News Releases
CV Sciences, Inc. to Announce Third Quarter 2020 Results on November 5, 2020
From GlobeNewswire News Releases
CV Sciences, Inc. Announces PlusCBD™ Brand Refresh and New Product Launches
PlusCBD™ refresh reflects the brand’s core mission to improve quality of life through nature and science 
From GlobeNewswire News Releases
CV Sciences, Inc. Announces Launch of CV™ Defense Daily Immune Support
CV™ Defense now available on CV Sciences website and launching on Amazon.com next week 
From GlobeNewswire News Releases
Market For CBD Infused Products Could Surpass $20 Billion By 2024
Financialnewsmedia.com News Commentary 
From PR Newswire
Market For CBD Infused Products Could Surpass $20 Billion By 2024
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CV Sciences, Inc. Launches New Website Reflecting Core Values and Mission of Improving Quality of Life Through Nature and Science
From GlobeNewswire News Releases
CV Sciences, Inc. to Participate in Alliance Global Partners Virtual Event
From GlobeNewswire News Releases
CV Sciences, Inc. Experts Contribute to Journal of Dietary Supplements First Special Issue on Cannabinoids
From GlobeNewswire News Releases
CV Sciences, Inc. Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Consumer CBD, CBG, CBN Based Products Expected to Continue to Grow at a Substantial Pace
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Consumer CBD, CBG, CBN Based Products Expected to Continue to Grow at a Substantial Pace
Financialnewsmedia.com News Commentary 
From PR Newswire
CV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product Line
THC-free Happy Lane™ expands CV Sciences’ sales channels and consumer access to safe and effective CBD 
From GlobeNewswire News Releases
CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line
Clinically researched wide spectrum proprietary plant-based formula supports immune system and respiratory health 
From GlobeNewswire News Releases
CV Sciences, Inc. to Announce Second Quarter 2020 Results on August 6, 2020
From GlobeNewswire News Releases
While FDA Advances Work Related to Cannabidiol Products CBD Usage Rates Are On The Rise
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
While FDA Advances Work Related to Cannabidiol Products CBD Usage Rates are on the Rise
Financialnewsmedia.com News Commentary 
From PR Newswire
Rise in CBD and CBG's Popularity Driven By Combination of Non-psychoactive Nature and Therapeutic Properties
Financialnewsmedia.com News Commentary 
From PR Newswire
Rise In CBD and CBG’s Popularity Driven By Combination Of Non-Psychoactive Nature and Therapeutic Properties
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ Products
From GlobeNewswire News Releases
CBD Infused Beverages Market Size Expected To Reach $2.8 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
CBD Infused Beverages Market Size Expected to Reach $2.8 Billion by 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020
From GlobeNewswire News Releases
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction
Formal Issuance of a U.S. Patent Strengthens Drug Development Business and Provides Valuable Intellectual Property to Address Large Unmet Market Opportunity 
From GlobeNewswire News Releases
CV Sciences, Inc. Reports First Quarter 2020 Financial Results
From GlobeNewswire News Releases
Governments Around the World Show Support for Medical Cannabis
FinancialBuzz.com News Commentary 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.